Patents by Inventor Shuangshuang DUAN

Shuangshuang DUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroisoquinoline derivatives, preparation process and use thereof
    Patent number: 11541049
    Abstract: Provided are tetrahydroisoquinoline derivatives, the preparation and use thereof. More specifically, provided are the tetrahydroisoquinoline derivatives or a pharmaceutically acceptable salt, ester, stereoisomer, tautomer, polymorph, solvate, isotopically labeled compound, metabolite or prodrug thereof. Further provided are a preparation process of the compound, the intermediates, a pharmaceutical composition comprising the compound and the use thereof in the treatment or prevention of a thromboembolic disorder.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: January 3, 2023
    Assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Yongyong Wu, Jiaqiang Cai, Guangchao Zhang, Shuangshuang Duan, Chaolei Wang, Lichun Wang, Jingyi Wang
  • HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Publication number: 20220144847
    Abstract: The present disclosure relates to a heterocyclic compound, a pharmaceutical composition comprising same, a preparation method therefor, and a use thereof. Specifically, the compound of the present invention is represented by formula (I), and used for preventing or treating a disease or condition related to RET activity.
    Type: Application
    Filed: February 11, 2020
    Publication date: May 12, 2022
    Inventors: Zhonghui Chen, Shuangshuang Duan, Guiying Li, Runfeng Han, Qizheng Sun, Liandong Jing, Xiaojun Han, Qiang Tian, Hongmei Song, Tongtong Xue, Jingyi Wang
  • TETRAHYDROISOQUINOLINE DERIVATIVES, PREPARATION PROCESS AND USE THEREOF
    Publication number: 20210052576
    Abstract: Provided are tetrahydroisoquinoline derivatives, the preparation and use thereof. More specifically, provided are the tetrahydroisoquinoline derivatives or a pharmaceutically acceptable salt, ester, stereoisomer, tautomer, polymorph, solvate, isotopically labeled compound, metabolite or prodrug thereof. Further provided are a preparation process of the compound, the intermediates, a pharmaceutical composition comprising the compound and the use thereof in the treatment or prevention of a thromboembolic disorder.
    Type: Application
    Filed: March 18, 2019
    Publication date: February 25, 2021
    Inventors: Yongyong WU, Jiaqiang CAI, Guangchao ZHANG, Shuangshuang DUAN, Chaolei WANG, Lichun WANG, Jingyi WANG